Solid support for synthesizing nucleic acid sequences and methods for making and using
AssigneeThe United States of America, as represented by the Secretary, Department of Health and Human Services
InventorsSerge L. Beaucage, Andrzej M. Grajkowski
Life of this patent
Estimating the term…
Abstract
Disclosed herein are embodiments of a solid support suitable for synthesizing nucleic acid sequences. The solid support may have a structure according to Formula I, where CPG is controlled pore glass, and m, n, x, y, R1 and R2 are as defined herein. Also disclosed are methods for making and using the solid support, kits including solid support, and a universal linker phosphoramidite suitable for use in the solid support.
Claims33
A solid support according to Formula I
- wherein:
- CPG is controlled pore glass;
- m is 2, 3, 4, 5 or 6;
- x is 1, 2, 3, 4 or 5;
- y is from 2 to 12;
- n is 3, 4, 5, 6, 7, 8, 9 or 10;
- R2 is H,
- p is 2, 3, 4, 5, 6, 7, 8, 9 or 10;
- R3 is H or
- R4 is H or OR6;
- R is PG or a nucleic acid sequence;
- R6 is pixyl, TBDMS, TBDPS, TMS, TES, or TIPS;
- T is 1, 2, 3, or 4;
- BP is a nucleic acid base where an exocyclic amine, if present, is protected;
- PG is a protecting group;
- and
- each R1 independently is a thermolabile phosphate protecting group having a structure
- wherein:
- X is O or S;
- R7 is H, Ra, ORa, SRa, or N(Rb)2;
- Ra is Rd;
- Rb is H, Rd or two Rbs together with the nitrogen to which they are attached, form a 3- to 7-membered heterocyclyl;
- Z is O, S, N(Rc), C(Rc)2 or C(Rc)2C(Rc)2;
- each Rc independently is H or Rd, or one Rd in combination with the C═X moiety and one Ra or Rb from R7 together form a 3- to 7-membered cycloaliphatic or heterocyclyl ring;
- Rd is alkyl, alkenyl, alkynyl, cycloalkyl, aryl, or aralkyl;
- each R8 independently is H or Rd, or one R8 together with Z forms an aryl ring;
- each R9 independently is H or Rd, or one R9 and one R8 together with the atoms to which they are attached, forms a moiety having a formula
- wherein r is 0 to 6;
- and
- each R10 independently is H, C1-6alkyl, NO2, —N(C1-6alkyl)2, —OC1-6alkyl, —SC1-6alkyl, —CN, or halogen, provided that the aromatic ring substituted with R10 is one carbon removed from the phosphate oxygen of Formula I.
A solid support according to Formula I
- wherein:
- CPG is controlled pore glass;
- m is 2, 3, 4, 5 or 6;
- x is 1, 2, 3, 4 or 5;
- y is from 2 to 12;
- n is 3, 4, 5, 6, 7, 8, 9 or 10;
- R2 is H,
- p is 2, 3, 4, 5, 6, 7, 8, 9 or 10;
- R3 is H or
- R4 is H or OR6;
- R5 is PG or a nucleic acid sequence;
- R6 is pixyl, TBDMS, TBDPS, TMS, TES, or TIPS;
- T is 1, 2, 3, or 4;
- BP is a nucleic acid base where an exocyclic amine, if present, is protected;
- PG is a protecting group;
- and
- each R1 independently is a thermolabile phosphate protecting group selected from:
A solid support according to Formula I
- wherein:
- CPG is controlled pre glass;
- m is 2, 3, 4, 5 or 6;
- x is 1, 2, 3, 4 or 5;
- y is from 2 to 12;
- n is 3, 4, 5, 6, 7, 8, 9 or 10;
- each R1 independently is C1-6alkyl, —(CH2)1-6CN, —(CH2)1-6OR′ or a thermolabile phosphate protecting group;
- R′ is aliphatic, aryl, or aralkyl;
- R2 is
- p is 2, 3, 4, 5, 6, 7, 8, 9 or 10;
- R3 is H or
- R4 is H or OR6;
- R5 is PG or a nucleic acid sequence;
- R6 is pixyl, TBDMS, TBDPS, TMS, TES, or TIPS;
- T is 1, 2, 3, or 4;
- BP is a nucleic acid base where an exocyclic amine, if present, is protected;
- and
- PG is a protecting group.
Dependencies are inferred from the claim text.